As of 2025-09-16, the Fair Value of Ligand Pharmaceuticals Inc (LGND) is -96.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 165.51 USD, the upside of Ligand Pharmaceuticals Inc is -158.46%.
With the market price of 165.51 USD and our fair value calculation, Ligand Pharmaceuticals Inc (LGND) is not a good investment. Investing in LGND stocks now will result in a potential loss of 158.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -3.00 | 57.10 | -33.40 | 52.15 | -4.03 | 13.76 |
| YoY growth | -100.48% | 2,003.33% | -158.49% | 256.15% | -107.73% | 378.56% |
| Market Cap (mil) | 3,244.09 |
| P/E | |
| Forward P/E | 1,224.43x |
| EPS | -3.87 |
| Avg earnings growth rate | 378.56% |
| TTM earnings | -75.86 |